Diabetes and Metabolism Journal

Korean Diabetes Association (대한당뇨병학회)
권호 표지

Taurine-Mediated Restoration of Glucose Sensitivity of Pancreatic Beta Cells in OLETF Rats

OLETF(Otsuka Long-Evans Tokushima fatty) 쥐의 췌장 베타세포에서 taurine에 의한 포도당 감수성의 개선

Kim, So-Yeon;Park, Keun-Gyu;Nam, Seong-Il;Lee, In-Kyu;Song, Dae-Kyu
김소연;박근규;남성일;이인규;송대규

  • Published : 20050500
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Matschinsky FM, Glaser B, Mangnuson MA: Pancreatic beta-cell glucokinase: closing the gap between theoretical concepts and experimental realities. Diabetes 47:307-15, 1998 https://doi.org/10.2337/diabetes.47.3.307
  2. Ashcroft FM, Gribble FM: ATP-sensitive $K^+$ channels and insulin secretion: their role in health and disease. Diabetologia 42:903-19, 1999 https://doi.org/10.1007/s001250051247
  3. Velho G, Vaxillaire M, Boccio V, Charpentier G, Froguel P: Diabetes complications in NlDDM kindred linked to the MODY3 locus on chromosome 12q. Diabetes Care 19:915-9, 1996 https://doi.org/10.2337/diacare.19.9.915
  4. Morales-Mulia M, Pasantes-Morales H, Moran J: Volume sensitive efflux of taurine in HEK293 cells overexpressing phospholemman. Biochim Biophys Acta 1496:252-60, 2000 https://doi.org/10.1016/S0167-4889(00)00023-9
  5. McBroom MJ, Elkhawad AO, Dlouha H: Taurine and ethanol-induced sleeping time in mice: route and time course effects. Gen Pharmacol 17:97-100, 1986 https://doi.org/10.1016/0306-3623(86)90018-2
  6. Sawamura A, Sperelakis N, Azurna J: Protective effect of taurine against decline of cardiac slow action potentials during hypoxia. Eur J Pharmacol 120:235-9, 1986 https://doi.org/10.1016/0014-2999(86)90546-7
  7. Han J, Kim E, Ho WK, Earm YE: Blockade of the ATP-sensitive potassium channel by taurine in rabbit ventricular myocytes. J Mol Cell Cardiol 28:2043-50, 1996 https://doi.org/10.1006/jmcc.1996.0197
  8. Tricarico D, Barbieri M, Camerino DC: Taurine blocks ATP-sensitive potassium channels of rat skeletal muscle fibres interfering with the sulphonylurea receptor. Br J Pharmacol 130:827-83, 2000 https://doi.org/10.1038/sj.bjp.0703385
  9. Hansen SH: The role of taurine in diabetes and the development of diabetic complications. Diabetes Metab Res Rev 17:330-46, 2001 https://doi.org/10.1002/dmrr.229
  10. Cherif H, Reusens B, Ahn MT, Hoet JI, Remade C: Effects of taurine on the insulin secretion of rat fetal islets from dams fed a low-protein diet. J Endocrinol 159:341-8, 1998 https://doi.org/10.1677/joe.0.1590341
  11. Tasaka Y, Iwatani M, Inoue S, Marumo K, Hirata Y: Plasma amino acid levels in hyperosmolar nonketotic diabetic coma. Horm Metab Res 15:59-61, 1983 https://doi.org/10.1055/s-2007-1018631
  12. Han J, Bae JH, Kim SY, Lee HY, Jang BC, Lee IK, Cho CH, Lim JG, Suh SI, Kwon TK, Park JW, Ryu SY, Ho WK, Earm YE, Song DK: Taurine increases glucose sensitivity of UCP2-overexpressing beta-cells by ameliorating mitochondrial metabolism. Am J Physiol Endocrinol Metab 287:E1008-18, 2004 https://doi.org/10.1152/ajpendo.00008.2004
  13. Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T: Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 41:1422-8, 1992 https://doi.org/10.2337/diabetes.41.11.1422
  14. Kawano K, Hirashima T, Mori S, Natori T: OLETF (Otsuka Long-Evans Tokushima Fatty) rat: a new NIDDM rat strain. Diabetes Res Clin Pract 24(Suppl): S317-20, 1994 https://doi.org/10.1016/0168-8227(94)90269-0
  15. Mori Y, Komiya H, Kurokawa N, Tajima N: Comparison of the effects of glimepiride and glibenclamide on adipose tissue tumour necrosis factor-alpha mRNA expression and cellularity. Diabetes Obes Metab 6:28-34, 2004 https://doi.org/10.1111/j.1463-1326.2004.00305.x
  16. Jia D, Yamamoto M, Otani M, Otsuki M: Bezafibrate on lipids and glucose metabolism in obese diabetic Otsuka Long-Evans Tokushima fatty rats. Metabolism 53:405-13, 2004 https://doi.org/10.1016/j.metabol.2003.10.006
  17. Kawano K, Mori S, Hirashima T, Man ZW, Natori T: Examination of the pathogenesis of diabetic nephropathy in OLETF rats. J Vet Med Sci 61:1219-28, 1999 https://doi.org/10.1292/jvms.61.1219
  18. Ishizawa K, Yoshizumi M, Tsuchiya K, Takishita E, Nakaya Y, Kishi K, Ebina Y, Houchi H, Minakuchi K, Tamaki T: Effects of losartan in combination with or without exercise on insulin resistance in Otsuka Long-Evans Tokushima Fatty rats. Eur J Pharmacol 430:359-67, 2001 https://doi.org/10.1016/S0014-2999(01)01405-4
  19. Iwai H, Ohno Y, Aoki N: The effect of leptin, tumor necrosis factor-alpha (TNF-alpha), and nitric oxide (NO) production on insulin resistance in Otsuka Long-Evans fatty rats. Endocr J 50:673-80, 2003 https://doi.org/10.1507/endocrj.50.673
  20. Luan Y, Hirashima T, Man ZW, Wang MW, Kawano K, Sumida T: Pathogenesis of obesity by food restriction in OLETF rats-increased intestinal monoacylglycerol acyltransferase activities may be a crucial factor. Diabetes Res Clin Pract 57:75-82, 2002 https://doi.org/10.1016/S0168-8227(02)00026-8
  21. Man ZW, Zhu M, Noma Y, Toide K, Sato T, Asahi Y, Hirashima T, Mori S, Kawano K, Mizuno A, Sano T, Shima K: Impaired beta-cell function and deposition of fat droplets in the pancreas as a consequence of hypertriglyceridemia in OLETF rat, a model of spontaneous NIDDM. Diabetes 46:1718-24, 1997 https://doi.org/10.2337/diabetes.46.11.1718
  22. Man ZW, Hirashima T, Mori S, Kawano K: Decrease in triglyceride accumulation in tissues by restricted diet and improvement of diabetes in Otsuka Long-Evans Tokushima fatty rats, a non-insulin-dependent diabetes model. Metabolism 49:108-14, 2000 https://doi.org/10.1016/S0026-0495(00)90913-2
  23. Burke CV, Buettger CW, Davis EA, McClane SJ, Matschinsky FM, Raper SE: Cell-biological assessment of human glucokinase mutants causing maturity-onset diabetes of the young type 2 (MODY-2) or glucokinase-linked hyperinsulinaemia (GK-HI). Biochem J 342: 345-52, 1999 https://doi.org/10.1042/0264-6021:3420345
  24. Tsuura Y, Ishida H, Okamoto Y, Kato S, Horie M, Ikeda H, Seino Y: Reduced sensitivity of dihydroxyacetone on ATP-sensitive $K^+$ channels of pancreatic beta cells in GK rats. Diabetologia 37: 1082-7, 1994 https://doi.org/10.1007/BF00418371
  25. Song DK, Ahn YH, Bae JR, Park WK, Hong YS, Ho WK, Earm YE: Evidence of enhancement of malateaspartate shuttle activity in beta cells of strepto:otocin-induced non-insulin-dependent diabetic rats. Metabolism 49:92-6, 2000 https://doi.org/10.1016/S0026-0495(00)90838-2
  26. Gembal M, Detimary P, Gilon P, Gao ZY, Henquin JC: Mechanisms by which glucose can control insulin release independently from its action on adenosine triphosphate-sensitive $K^+$ channels in mouse B cells. J Clin Invest 91:871-80, 1993 https://doi.org/10.1172/JCI116308
  27. Steele DS, Smith GL, Miller DJ: The effects of taurine on $Ca^2+$$Ca^2+$ sensitivity of chemically skinned rat heart. J Physiol 422:499-511, 1990 https://doi.org/10.1113/jphysiol.1990.sp017997
  28. De Luca A, Piemo S, Camerino DC: Effect of taurine depletion on excitation-contraction coupling and Clconductance of rat skeletal muscle. Eur J Pharmacal 296:215-22, 1996 https://doi.org/10.1016/0014-2999(95)00702-4
  29. Igisu H, Izumi K, Goto I, Kina K: Effects of taurine on the ATPase activity in the human erythrocyte membrane. Pharmacology 14:362-6, 1976 https://doi.org/10.1159/000136616
  30. Sebring LA, Huxtable RJ: Taurine modulation of calcium binding to cardiac sarcolemma. J Pharmacol Exp Ther 232:445-51, 1985
  31. Lombardini JB: Effects of taurine and mitochondrial metabolic inhibitors on ATP-dependent $Ca^2+$ uptake in synaptosomal and mitochondrial subcellular fractions of rat retina. J Neurochem 51:200-5, 1988 https://doi.org/10.1111/j.1471-4159.1988.tb04856.x
  32. McCormack JG, Halestrap AP, Denton RM: Role of calcium ions in regulation of mammalian intramitochondrial metabolism. Physiol Rev 70:391-425, 1990 https://doi.org/10.1152/physrev.1990.70.2.391
  33. Kuriyama K, Muratmatsu M, Nakagawa K, Kakita K: Modulating role of taurine on release of neurotransmitters and calcium transport in excitable tissues. In Barbeau A, Huxtable RJ, editors. Taurine and Neurological Disorders. p. 201-216, New York, Raven Press, 1978
  34. Palmi M, Fusi F, Y oumbi G, Frosini M, Bianchi L, Della Corte L, Sgaragli GP, Tipton KF: Effects of taurine and structurally related analogues on $Ca^2+$ uptake and respiration rate in rat liver mitochondria. Adv Exp Med Biol 403:117-24, 1996
  35. Palmi M, Youmbi GT, Fusi F, Sgaragli GP, Dixon HB, Frosini M, Tipton KF: Potentiation of mitochondrial $Ca^2+$ sequestration by taurine. Biochem Pharmacol 58: 1123-31, 1999 https://doi.org/10.1016/S0006-2952(99)00183-5
  36. Mizushima S, Nara Y, Sawamura M, Yamori Y: Effects of oral taurine supplementation on lipids and sympathetic nerve tone. Adv Exp Med Biol 43:615-22, 1996